Key Challenges in the Latin American Cold Chain

The loss of patent protection on top-selling medicines has slowed the sales growth of Pharmaceutical and Biotech companies in the U.S. and Europe. The market in Latin America, however, is booming and is
currently growing two to three times faster than the U.S. and Europe and will surge to $124 billion by 2018.

Given this knowledge, we have identified the main challenges of the cold chain in Latin America in this handy infographic.

Please note: That all fields marked with an asterisk (*) are required.